The mRNA technology that helped end the COVID-19 pandemic may now hold the key to defeating cancer, and it exists because of ...
KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...
RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...
TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...
A new study shows mRNA-based treatment can protect muscle tissue from snake venom damage, offering a potential boost to ...
Health and Human Services Secretary Robert F. Kennedy Jr. speaks as President Donald Trump listens at an event to promote his proposal to improve Americans’ access to their medical records in the East ...
Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the results of a clinical trial.
In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback